[Expression of Concern] Metformin inhibits growth and sensitizes osteosarcoma cell lines to cisplatin through cell cycle modulation
Oncology Reports · 08.04.2026 · 55 (6) · 1-1
DOI: 10.3892/or.2026.9116 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Reports, online erschienen am 08.04.2026. Verfasst von Irene Quattrini und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Experimental Oncology, Rizzoli Orthopaedic Institute, I-40136 Bologna, Italy. Hauptthemen laut MEDLINE: Osteosarcoma, Metformin, Cisplatin, Cell Cycle. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Experimental Oncology, Rizzoli Orthopaedic Institute, I-40136 Bologna, Italy.
- Chemotherapy Ward, Rizzoli Orthopaedic Institute, I-40136 Bologna, Italy.
Zitieren
APA
Quattrini, I., Conti, A., Pazzaglia, L., Novello, C., Ferrari, S., Picci, P., & Benassi, M. S. (2026). [Expression of Concern] Metformin inhibits growth and sensitizes osteosarcoma cell lines to cisplatin through cell cycle modulation. Oncology Reports, 55(6), 1-1. https://doi.org/10.3892/or.2026.9116
Vancouver
Quattrini I, Conti A, Pazzaglia L, Novello C, Ferrari S, Picci P, et al. [Expression of Concern] Metformin inhibits growth and sensitizes osteosarcoma cell lines to cisplatin through cell cycle modulation. Oncology Reports. 2026;55(6):1-1. doi:10.3892/or.2026.9116
BibTeX
@article{Quattrini2026,
author = {Quattrini, Irene and Conti, Amalia and Pazzaglia, Laura and Novello, Chiara and Ferrari, Stefano and Picci, Piero and Benassi, Maria Serena},
title = {[Expression of Concern] Metformin inhibits growth and sensitizes osteosarcoma cell lines to cisplatin through cell cycle modulation},
journal = {Oncology Reports},
year = {2026},
volume = {55},
number = {6},
pages = {1--1},
doi = {10.3892/or.2026.9116}
}
EUVIMED